Boston Scientific Archives | Vein Therapy News

Business News

MILLIONS OF COVID-19 TEST KITS BY APRIL

Diagnostics manufacturers with government approval to test for the coronavirus strain COVID-19 are promising millions of tests kits to be produced weekly by the end of March and be commercially available. The Advanced Medical Technology Association (AdvaMed) said at…

March232020November252024

Business News

COVID-19 AND OUR COMMITMENT TO OUR ADVERTISING PARTNERS

Dear Vein Therapy News clients: The health and safety of our clients and employees is our highest priority. In normal times, we would see you at medical conferences and site visits. Because of the danger of contracting or spreading…

VICI VENOUS STENT: FDA OKs VICI Venous Stent to treat Iliofemoral obstructive disease

The U.S Food and Drug Administration has approved Boston Scientific’s VICI Venous Stent System for the treatment of iliofemoral venous obstructive disease, which occurs when the flow of blood through the veins located deep in the pelvic region becomes…

FDA evaluating stents, balloons with paclitaxel coating following JAHA evaluation

A December study in The Journal of the American Heart Association by Konstantinos Katsanos, MD, of Rion, Greece, et al, reported a higher risk of death after balloons and stents used to open vessels in the legs were coated with…

Business News

BOSTON SCIENTIFIC ACQUIRES REST OF MILLIPEDE IN $4.8 BILLION YEAR-LONG SHOPPING SPREE

After a year of holding the option to acquire Millipede, Boston Scientific decided to do it a year before the option ran out. When the pair signed the agreement last January, Boston Scientific paid $90 million for a portion of…

December312018October252024

BOSTON SCIENTIFIC LINES UP FINANCING FOR ITS $4B BTG ACQUISITION

Now that everyone has said yes, Boston Scientific has gone to the banks to sign a number of new lending agreements, including a large credit facility it could use to finance its $4.2 billion acquisition offer for British medical device…

December302018October252024

BOSTON SCIENTIFIC ACQUIRING BTG

Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care…

November212018October252024